HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
BIOBOARD - EUROPE
Teesside University pioneering life-saving research

Life-saving research to provide early detection of an illness which kills millions of people each year is being pioneered by academics at Teesside University.

The £1.3 million CE-microArray project, which is being coordinated by Teesside University and includes eight other European academic and SME partners, has the potential to dramatically reduce the amount of time it takes to diagnose patients at risk of developing sepsis.

Sepsis is caused by the body's overreaction to an infection and can be triggered either directly by infection or may occur after medical treatment or surgery.

It is estimated that it is the cause of approximately half a million deaths in Europe each year.

Current methods of diagnosing can take up to 72 hours.

In cases of severe sepsis, an earlier diagnosis which leads to the start of antibiotic treatment by just one hour could lead to a 6–10% reduction in mortality rates.

The CE-microArray project plans to use 'cavity enhanced absorption spectroscopy' to provide more sensitive, reliable and speedier diagnoses of patients at risk of developing sepsis.

The technique involves improving the sensitivity of blood tests which are based on the absorption of light by passing light many times through the sample.

This could lead to a test which could be up to 100 times more sensitive than conventional testing.

The project is being coordinated by Dr Meez Islam, a Reader in Physical Chemistry in the School of Science & Engineering at Teesside University.

One of the SME partners in the project is Anasyst, a company specializing in novel analytical systems which was spun out of Teesside University research.

Dr Islam said: "We've seen that this testing can work in specialized cases and anything that can speed up the diagnosis times and start treatment earlier, even by a small amount, could potentially save thousands of lives each year.

"In the United States alone, the cost of treatment as a result of hospitalization for sepsis is thought to be about $17 billion annually so it could have a huge benefit for healthcare budgets as well."

Professor Zulf Ali, the Dean of Teesside University's Graduate Research School, and CEO of Anasyst, added: "This is an extremely prestigious project which showcases the high quality research which is done at Teesside and the way in which we can work with the healthcare industry to provide practical solutions to global problems."

Source: PR Newswire

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy